|
|
Article: Bristol Wants ImClone Deal Slashed
- Article from:
- AP Online
- Article date:
- February 8, 2002
- Author:
CopyrightThis material is published under license from the Associated Press. All inquiries regarding rights should be directed to the Associated Press. (Hide copyright information)
|
00-00-0000
Dateline: SAN FRANCISCO
Stung by a soured drug partnership with ImClone Systems Inc., Bristol-
Myers Squibb Co. is demanding its $2 billion deal with the biotechnology
company be cut nearly in half, a source close to the deal said Thursday.
The drug titan sent ImClone a one-page letter earlier this week demanding
cancellation of $800 million in milestone payments Bristol would owe
ImClone once the experimental cancer drug Erbitux cleared two regulatory
hurdles, including marketing approval from the U.S. Food and Drug
Administration, the source said.
Bristol already has written off $735 million of the $1.2 billion it
invested in ImClone nearly five months ago. ImClone's ...